Publications by authors named "Eun-Joo Nam"

Chlorhexidine (CHX) is an effective antibacterial agent and is used in dental treatment in several formulations. The aim of this study was to compare the effectiveness of CHX solution and CHX gel on dental plaque inhibition and gingivitis relief by a randomized clinical trial. Thirty-eight participants were randomly divided into two groups: control group (0.

View Article and Find Full Text PDF
Article Synopsis
  • A dual agonist of glucagon-like peptide (GLP)-1 and GLP-2 (GLP1/2-Fc) was tested in mice with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), conditions that currently lack FDA-approved treatments.
  • * The treatment showed significant improvements by reducing body weight, glucose levels, liver fat, and inflammation, while enhancing liver fibrosis, insulin sensitivity, and gut health.
  • * Fecal microbiota transplantation (FMT) was used to further explore the protective effects of GLP1/2-Fc, indicating that it may enhance the treatment's outcomes when combined with other therapies.*
View Article and Find Full Text PDF

Objectives: The choice of doctor is an important issue for patients with cancer, and the reputation of the doctor is the single most important factor for patients to choose a doctor. Media are providing information about the 'best cancer doctor', but they vary widely in their selection methodology. We investigated cancer physicians' attitudes towards the selection of the 'best cancer doctor' by the media, by comparing two different selection methodologies: selection by media personnel or selection through peer-review system.

View Article and Find Full Text PDF

Both active and passive immunization to eliminate amyloid plaques from the brain of patients with Alzheimer's disease (AD) have confirmed that amyloid beta (Abeta) vaccination does not only result in clearance of Abeta plaques but improves behavioral-cognitive deficits in animal models of AD. In the present study, the levels of naturally occurring serum antibodies against Abeta were measured in Tg2576 mice at various ages using ELISA to determine the relationship between aging and the level of anti-Abeta autoantibody. The level of anti-Abeta antibody fell significantly at the age of 9 months, at the age when amyloid plaques started to appear in the brain of Tg2576 mice, and was persistently low thereafter.

View Article and Find Full Text PDF